A Phase I Clinical Study of Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract.
Phase of Trial: Phase I
Latest Information Update: 19 Nov 2014
At a glance
- Drugs Bexarotene (Primary) ; Erlotinib (Primary)
- Indications Head and neck cancer; Lung cancer; Oesophageal cancer
- Focus Adverse reactions; Biomarker
- 12 Nov 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Aug 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Planned End Date changed from 1 Dec 2012 to 1 Jan 2013 as reported by ClinicalTrials.gov.